Early Edition with Ryan BridgeEarly Edition with Ryan Bridge

Adele Gautier: Breast Cancer Foundation researcher discusses Pharmac consideration of switch to Herzuma

View descriptionShare
 

Changes are on the cards for some breast cancer patients.

Pharmac is consulting on a drug switch proposal to replace the current expired one.

Herzuma is said to be more safe and cost effective, but at what there are concerns about whether all patients will be suited to it.

Breast Cancer Foundation's Research and Strategics Manager, Adele Gautier, joined Kate Hawkesby.

LISTEN ABOVE

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Early Edition with Ryan Bridge

A fresh and intelligent start to your day - catch the very latest international and domestic news de 
Social links
Follow podcast
Recent clips
Browse 4,974 clip(s)